6533b7dbfe1ef96bd127133b

RESEARCH PRODUCT

Management of Osteoporosis in Postmenopausal Women

Juan José Hidalgo-moraA. Cano-marquinaAnna SzeligaAntonio CanoMiguel Angel García-pérez

subject

musculoskeletal diseasesmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentOsteoporosisEstrogen receptorDiseasemedicine.diseaseBone remodelingResorptionMenopauseEndocrinologymedicine.anatomical_structureInternal medicinemedicineBone marrowHormone therapybusiness

description

Osteoporosis is a noncommunicable disease with increasing incidence at a global level. The burden of the disease particularly concerns women. A drastic and rapid decline in the circulating levels of estrogens, a key regulator of bone metabolism, is responsible for the increase in bone loss after menopause. Cells with a role in bone metabolism, osteoblasts, osteoclasts and osteocytes, have estrogen receptors. The fall in estrogens increases the differentiation of osteoclasts from progenitors in the bone marrow. A significant expansion in the resorption process follows.

https://doi.org/10.1007/978-3-030-13936-0_24